We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global X-Ray Detectors Market to Surpass USD 4.5 Billion Due to Increasing Use of CT Scans for COVID-19 Diagnosis

By LabMedica International staff writers
Posted on 19 Oct 2021
Print article
Illustration
Illustration

The global X-ray detectors market is projected to expand at a CAGR of 5.9% during the forecast period of 2021-2031 to reach USD 4.6 billion by 2031, driven mainly by the rising use of radiographic chest scans for COVID-19 diagnosis.

These are the latest findings of Transparency Market Research (Albany, NY, USA), a next-generation market intelligence provider. The market growth will be further aided by the increasing use of X-ray detectors in several applications, growing incidences of gastrointestinal, cardiovascular, oral, and genitourinary disorders and introduction of innovative X-ray detectors for security, industrial, medical, dental, veterinary, and other purposes. In addition, technological advancements that will enable detectors to provide better detail, higher resolution, and decreased exposure will also provide a boost to the global X-ray detectors market.

The use of X-ray detectors for COVID-19 diagnosis will prove to be a key contributor to market growth. Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests are accurate in detecting COVID-19 in individuals, but are very complicated, time-consuming, and costly. Stakeholders in the X-ray detectors market are taking advantage of this opportunity to increase the availability of radiological examination through X-ray such as CT (Computed Tomography) scans, which is a cost-efficient and easily available option. The rising use of X-ray detectors for radiographic chest scans during the COVID-19 pandemic offers substantial growth opportunities.

These detectors are also being optimized by the players for various industrial inspection and material sorting applications. In addition, wider application of X-ray detectors in image-guided radiation therapy, fluoroscopy, digital radiography, cone beam CT, digital tomosynthesis, and others are expected to further fuel market growth. The growing focus of several countries on developing a well-established healthcare infrastructure is also likely to drive the growth of the global X-ray detectors market.

Flat panel detectors are expected to observe a rise in demand, as they offer various advantages such as uniform imaging quality, less image distortion, low time consumption, good reproducibility, and better patient condition access, among others. In addition, they are proven to be very successful in high exposure interventional procedures. Among panel types, the large panel category of the X-ray detectors market is expected to witness promising growth. The growing number of patients undergoing diagnostic imaging tests, and expanding adoption of new and advanced large panel detectors are likely to propel the growth of the X-ray detectors market.

Geographically, North America held the largest share of the global X-ray detectors market in 2020 and is expected to maintain its position during the forecast period. The growing number of dental CBCT scans in the US due to increasing dental diseases among a considerable share of its population is anticipated to propel the growth of the North American X-ray detectors market. Furthermore, the Asia Pacific X-ray detectors market is also projected to grow rapidly during the forecast period. Increasing efforts by several countries in the region to develop a well-established healthcare infrastructure, coupled with novel product launches in China and Japan, are expected to fuel the growth of the X-ray detectors market in the Asia Pacific.

Related Links:
Transparency Market Research 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more